Jalali Tehrani Hora, Parivar Kazem, Ai Jafar, Kajbafzadeh Abdolmohammad, Rahbarghazi Reza, Hashemi Mehrdad, Sadeghizadeh Majid
Depatment of Biology, Science and Research Branch Islamic Azad University Tehran Iran.
Department of Tissue Engineering, Faculty of Advance Technology, University of Medical Sciences, Tehran, Iran.
Iran J Pharm Res. 2014 Spring;13(2):659-64.
Human endometrium contains mesenchymal stem cells (eMSC) which have the ability to differentiate into three cell lineages and the potential in therapeutic applications. We hypothesize that using environmental induction in culture media such as dexamethasone, human recombinant insulin and human epidermal growth factor (hEGF) can differentiate endometrial stem cells into myoblast. These agents have a broad range of effects in myoblast differentiation in-vitro. We used immunohystochemistry analysis and RT -PCR to evaluate the presence of skeletal muscle - specific proteins some of which are expressed in the early stage of differentiation including myoD and Desmin which expressed at later stages of differentiation. In conclusion eMSC can differentiate in culture media which contains above mentioned factors and use for therapeutic purpose in muscular degenerative disease.
人子宫内膜含有间充质干细胞(eMSC),其具有分化为三种细胞谱系的能力以及治疗应用潜力。我们假设,在培养基中使用地塞米松、人重组胰岛素和人表皮生长因子(hEGF)等环境诱导剂可将子宫内膜干细胞分化为成肌细胞。这些试剂在体外对成肌细胞分化具有广泛影响。我们使用免疫组织化学分析和逆转录聚合酶链反应(RT-PCR)来评估骨骼肌特异性蛋白的存在,其中一些蛋白在分化早期表达,包括肌分化抗原(MyoD),而结蛋白在分化后期表达。总之,eMSC可在含有上述因子的培养基中分化,并用于肌肉退行性疾病的治疗。